Farmaceutica Remedia SA (RMAH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Ropharma SA

Farmaceutica Remedia SA

Why is Farmaceutica Remedia SA ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

10.75%

EBIT Growth (5y)

-15.65%

EBIT to Interest (avg)

16.94

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.61

Sales to Capital Employed (avg)

Tax Ratio

46.24%

Dividend Payout Ratio

54.35%

Pledged Shares

Institutional Holding

ROCE (avg)

38.77%

ROE (avg)

17.17%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.10

EV to EBIT

1.50

EV to EBITDA

1.37

EV to Capital Employed

1.40

EV to Sales

0.04

PEG Ratio

0.02

Dividend Yield

4.60%

ROCE (Latest)

93.15%

ROE (Latest)

16.10%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Farmaceutica Remedia SA

Net Sales - Quarterly

Highest at RON 146 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (RON MM)

Operating Profit (PBDIT) - Quarterly

Highest at RON 4 MM.

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (RON MM)

Operating Profit Margin - Quarterly

Highest at 2.59%

in the last five quarters

MOJO Watch

Company's efficiency has improved

Operating Profit to Sales (RON MM)

Here's what is not working for Farmaceutica Remedia SA

Profit Before Tax less Other Income (PBT) - Quarterly

Lowest at RON 1 MM.

in the last five periods

MOJO Watch

Near term PBT trend is negative

PBT less Other Income (RON MM)

Profit After Tax (PAT) - Quarterly

Lowest at RON 1 MM.

in the last five periods

MOJO Watch

Near term PAT trend is negative

PAT (RON MM)

Earnings per Share (EPS) - Quarterly

Lowest at RON 0.01

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (RON)